Assessment of the Beryllium Lymphocyte Proliferation Test Using Statistical Process Control

REFERENCES

• Barna B. P., Culver D. A., Yen-Lieberman Y., Dweik R. A., Thomassen M. J. Clinical application of beryllium lymphocyte proliferation testing. Clin. Diag. Lab. Immunol. 2003; 10: 990–994, [CSA]
   PubMedGoogle Scholar
• Berger B. M. Statistical quality assurance in cytology. Use of the Pathfinder to continuously assess screener process control in real time. Acta Cytol. 1996; 40: 97–106, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Boggs P. B., Hayati F., Washburne W. F., Wheeler D. A. Using statistical process control charts for the continual improvement of asthma care. J. Commun. J. Qual. Improv. 1999; 25: 163–181, [CSA]
   PubMedGoogle Scholar
• Borak J. The beryllium occupational exposure limit: Historical origin and current inadequacy. J. Occup. Environ. Med. 2006; 48(2)109–116, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Carey R. G., Lloyd R. C. Measuring quality improvement in healthcare: A guide to statistical process control applications. Quality Resources, New York 1995
   Google Scholar
• Cederbrant K., Hultman P., Marcusson J. A., Tibbling L. In vitro lymphocyte proliferation as compared to patch test using gold, palladium and nickel. Int. Arch. Allergy Immunol. 1997; 112: 212–217, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Curtis G. H. Cutaneous hypersensitivity due to beryllium: A study of thirteen cases. Arch. Derm. Syphilol. 1951; 64: 470–482, [CSA]
   Google Scholar
• Deubner D. C., Goodman M., Iannuzzi J. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): Preliminary analysis of the ongoing workforce survey. Appl. Occup. Environ. Hyg. 2001; 16: 521–526, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Doty L. Statistical process control. Industrial Press, New York 1996
   Google Scholar
• Frome E. L., Smith M. H., Littlefield L. G., Neubert R. L., Colyer S. P. Statistical methods for the blood beryllium lymphocyte proliferation test. Environ. Health Perspect. 1996; 104S: 957–968, [INFOTRIEVE], [CSA]
   Google Scholar
• Frome E. L., Newman L. S., Cragle D. L., Coyler S. P., Wambach P. F. Identification of an abnormal beryllium lymphocyte proliferation test. Toxicology 2003; 183: 39–56, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kaminsky F. C., Maleyeff J., Mullins D. L. Using SPC (statistical process control) to analyze measurements in a healthcare organization. J. Health Risk Manage. 1998; 18: 36–46, [CSA]
   PubMedGoogle Scholar
• Kolanz M. Introduction to beryllium: Uses, regulatory history, and disease. Appl. Occup. Environ. Hyg. 2001; 16: 559–567, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kreiss K., Newman L. S., Mroz M. M., Campbell P. A. Screening blood test identifies subclinical beryllium disease. J. Occup. Med. 1989; 31: 603–608, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Kreiss K., Wasserman S., Mroz M. M., Newman L. S. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure–disease relations. J. Occup. Med. 1993; 35: 267–274, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Kreiss K., Mroz M. M., Newman L. S., Martyny J., Zhen B. Machining risk of beryllium disease and sensitization with median exposures below 2 μg/m3. Am. J. Ind. Med. 1996; 30: 16–25, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kreiss K., Mroz M. M., Zhen B., Wiedemann H., Barna B. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup. Environ. Med. 1997; 54: 605–612, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Laine J., Happonen R. P., Vainio O., Kalimo K. In vitro lymphocyte proliferation test in the diagnosis of oral mucosal hypersensitivity reactions to dental amalgam. J. Oral Pathol. Med. 1997; 26: 362–366, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lalla M., Virolainen M. Blood lymphoblast proliferation in vivo in cutaneous drug hypersensitivity reactions. Int. Arch. Allergy Appl. Immunol. 1974; 46: 289–299, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Littell R. C., Milliken G. A., Stroup W. W. SAS system for mixed models. SAS Institute, Inc, Cary, NC 1996
   Google Scholar
• McAree P. W., Bauer K. W., Jr., Louis D. J., Jackson J. A. Use of statistical process control for surveillance of pulmonary dysfunction in groups in the workplace. Health Care Manage. Sci. 1998; 1: 53–59, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Montgomery D. C. Introduction to Statistical Quality Control. John Wiley, New York 2001
   Google Scholar
• Quesenberry C. P. Statistical process control geometric Q-chart for nosocomial infection surveillance. Am. J. Infect. Control 2000; 28: 314–320, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rasanen L., Tuomi M. L. Diagnostic value of the lymphocyte proliferation test in nickel contact allergy and provocation in occupational coin dermatitis. Contact Dermatitis 1992; 27: 250–254, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rasanen L., Sainio H., Lehto M., Reunala T. Lymphocyte proliferation test as a diagnostic aid in chromium contact sensitivity. Contact Dermatitis 1991; 25: 25–29, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Schwab R. A., DelSorbo S. M., Cunningham M. R., Craven K., Watson W. A. Using statistical process control to demonstrate the effect of operational interventions on quality indicators in the emergency department. J. Health Qual. 1999; 21: 38–41, [CSA]
   PubMedGoogle Scholar
• Stange A. W., Furman F. J., Hilmas D. E. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance. Am. J. Ind. Med. 2004; 46: 453–462, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Stejskal V. D., Danersund A., Lindvall A. Metal-specific lymphocytes: Biomarkers of sensitivity in man. Neuroendocrinol. Lett. 1999; 20: 289–298, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Stokes R. F., Rossman M. D. Blood cell proliferation response to beryllium: Analysis by receiver-operating characteristics. J. Occup. Med. 1991; 33: 23–28, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Williams W. R., Williams W. J. Development of beryllium lymphocyte transformation tests in chronic beryllium disease. Int. Arch. Allergy Appl. Immunol. 1982; 67: 175–180, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Yoshida T., Shima S., Nagaoka K., Taniwaki H., Wada A., Kurita H., Morita K. A study on the beryllium lymphocyte transformation test and the beryllium levels in the working environment. Ind. Health 1997; 35: 374–379, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar